GPC3 and hepatocellular carcinoma: We immunohistochemically demonstrated that most (94%) of MCT4+ HCC cases in our cohort showed GPC3 positivity, and nearly 80% of MCT4+ HCC cases exhibited reciprocal or synergistic expression pattern between MCT4 and GPC3.